glp-1 drugs and addiction receptor agonists show promise in treating substance use disorders GLP‑1 drugs may fight addiction
Description
The goal is consistency, not forcing large amounts of intake at once
Abstract Increasing use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) raises concern for interactions with warfarin
Overgaard RV, Lindberg SO, Thielke D
The practical takeaway: keep your follow-up labs, because those numbers, not the scale, are the real scoreboard
95% CI 0.8, 2.4)
These considerations argue for a more nuanced evaluation of centrally acting appetite peptides rather than categorical exclusion
